Streetbeat News

CLOV

Clover Health Investments, Corp.

https://www.cloverhealth.com

Industry

Medical - Healthcare Plans

Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.

Open

3.65

Mkt cap

1.9B

Volume

3.3M

High

3.73

P/E Ratio

-40.89

52-wk high

4.87

Low

3.56

Div yield

N/A

52-wk low

0.61

Clover Health's Q3 2024 results show an 8% revenue increase, driven by Medicare Advantage premiums. Cost control measures have reduced expenses and losses, while strong cash reserves and no long-term debt position the company for strategic investments in its Clover Assistant platform.

Portfolio Pulse from

January 16, 2025 | 4:45 pm

Clover Health Investments, Corp. (Nasdaq: CLOV) reported a 27% year-over-year growth in its Medicare Advantage membership, surpassing 100,000 members after a strong Annual Election Period. Approximately 95% of these members are enrolled in Clover's 4-Star PPO plan.

Portfolio Pulse from

January 13, 2025 | 2:15 pm

Counterpart Health, a subsidiary of Clover Health Investments, has deployed its AI-powered Counterpart Assistant technology within Duke Connected Care, part of Duke University Health System.

Portfolio Pulse from

January 07, 2025 | 2:15 pm

The article highlights four MedTech stocks - DOCS, CLOV, CLPT, and HIMS - that have gained over 100% in 2024 and are expected to continue providing promising returns.

Portfolio Pulse from

December 23, 2024 | 5:15 pm

Clover Health's recent earnings report shows mixed results, with revenue growth but a significant share price drop. Despite this, operational efficiency is improving, and Wall Street remains optimistic with positive ratings and a potential 46% upside.

Portfolio Pulse from

December 21, 2024 | 7:45 am

Clover Health Investments is making financial progress in 2024 with innovative Medicare Advantage plans and technology-driven healthcare solutions. The company achieved a 4.0 rating for its PPO plan, indicating improved quality of care and potential for higher CMS reimbursements. Despite a slight membership decline, net income losses have decreased significantly from 2022 to 2024.

Portfolio Pulse from

December 11, 2024 | 12:30 pm

Clover Health Investments (CLOV) has formed a hammer chart pattern, suggesting support and potential trend reversal. Upward earnings estimate revisions further support a positive outlook.

Portfolio Pulse from

December 05, 2024 | 4:00 pm

Clover Health's stock has dipped 32% after Q3 earnings, presenting a potential buying opportunity. The company is improving its financial performance and has received a 4-star rating upgrade for 2026, which could boost market share and secure more deals.

Portfolio Pulse from

November 18, 2024 | 5:00 pm

Clover Health Investments (CLOV) has seen a significant drop of 26.32% over the past four weeks, making it technically oversold. This suggests a potential exhaustion of selling pressure. Additionally, Wall Street analysts are revising earnings estimates higher, indicating a possible trend reversal for CLOV in the near term.

Portfolio Pulse from

November 15, 2024 | 4:00 pm

Clover Health Investments (CLOV) has experienced a significant decline of 25.82% over the past four weeks. However, the stock is now in oversold territory, and Wall Street analysts are revising earnings estimates higher, suggesting a potential trend reversal.

Portfolio Pulse from

November 14, 2024 | 3:45 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.